What's NEXT for CML-NGS mutation screening

Naranie Shanmuganathan; Timothy P. Hughes

doi:10.1182/blood.2019004559

What's NEXT for CML-NGS mutation screening

Naranie Shanmuganathan, Timothy P. Hughes

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	515-516
Number of pages	2
Journal	Blood
Volume	135
Issue number	8
DOIs	https://doi.org/10.1182/blood.2019004559
Publication status	Published or Issued - 20 Feb 2020

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2019004559

Cite this

@article{ab6e59d5b4e644f1a7ec0ac5cf274a95,

title = "What's NEXT for CML-NGS mutation screening",

author = "Naranie Shanmuganathan and Hughes, {Timothy P.}",

note = "Funding Information: Conflict-of-interest disclosure: N.S. received honoraria from Novartis and travel and accommodation expenses from Novartis, Gilead, Amgen, and Janssen. T.P.H. has served as a consultant for and has received research funding and honoraria from Novartis and Bristol-Myers Squibb. Prepublished online as Blood First Edition paper, December 26, 2019",

year = "2020",

month = feb,

day = "20",

doi = "10.1182/blood.2019004559",

language = "English",

volume = "135",

pages = "515--516",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "8",

}

TY - JOUR

T1 - What's NEXT for CML-NGS mutation screening

AU - Shanmuganathan, Naranie

AU - Hughes, Timothy P.

N1 - Funding Information: Conflict-of-interest disclosure: N.S. received honoraria from Novartis and travel and accommodation expenses from Novartis, Gilead, Amgen, and Janssen. T.P.H. has served as a consultant for and has received research funding and honoraria from Novartis and Bristol-Myers Squibb. Prepublished online as Blood First Edition paper, December 26, 2019

PY - 2020/2/20

Y1 - 2020/2/20

UR - http://www.scopus.com/inward/record.url?scp=85079825124&partnerID=8YFLogxK

U2 - 10.1182/blood.2019004559

DO - 10.1182/blood.2019004559

M3 - Editorial

C2 - 32078686

AN - SCOPUS:85079825124

SN - 0006-4971

VL - 135

SP - 515

EP - 516

JO - Blood

JF - Blood

IS - 8

ER -

What's NEXT for CML-NGS mutation screening

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this